Marwân‐al‐Qays Bousmah

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

Alexandra Calmy, Tamara Tovar-Sanchez, Charles Kouanfack et al. · The Lancet HIV · 2020 · 164 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Medicine and democracy: The importance of institutional quality in the relationship between health expenditure and health outcomes in the MENA region

Marwân‐al‐Qays Bousmah, Bruno Ventelou, Mohammad Abu‐Zaineh · Health Policy · 2016 · 53 citations · Full text

Public Affairs, Health Policy, Health Systems +17

Health differentials between citizens and immigrants in Europe: A heterogeneous convergence

Marwân‐al‐Qays Bousmah, Mohammad Abu‐Zaineh · Health Policy · 2018 · 41 citations · Full text

Public Health, Health Sciences, Population Health Sciences +14

Reassessing the demand for community-based health insurance in rural Senegal: Geographic distance and awareness

Marwân‐al‐Qays Bousmah, Sylvie Boyer, Richard Lalou et al. · SSM - Population Health · 2021 · 22 citations · Full text

Public Affairs, Health Policy, Insurance +16

Effects of a free health insurance programme for the poor on health service utilisation and financial protection in Senegal

Marwân‐al‐Qays Bousmah, Pathé Diakhaté, Grâce à Dieu Toulao et al. · BMJ Global Health · 2022 · 20 citations · Full text

Public Affairs, Health Policy, Insurance +12